(Q35695971)

9 August 2017

1 reference

title

Applications of the P50 evoked response to the evaluation of cognitive impairments after traumatic brain injury (English)

1 reference

9 August 2017

main subject

traumatic brain injury

0 references

cognitive dysfunction

1 reference

David B Arciniegas

1

1 reference

9 August 2017

Jeannie L Topkoff

series ordinal

2

1 reference

9 August 2017

language of work or name

1 reference

1 February 2004

1 reference

Physical medicine and rehabilitation clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

15

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

177-203, viii

1 reference

The incidence, causes, and secular trends of head trauma in Olmsted County, Minnesota, 1935-1974.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Comparative head trauma experiences in two socioeconomically different Chicago-area communities: a population study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Epidemiologic features of head injury in a predominantly rural population.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Neuropsychological sequelae of minor head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Disability Caused by Minor Head Injury

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Moderate head injury: completing the clinical spectrum of brain trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Neuropsychological and psychosocial consequences of minor head injury

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Sequelae of concussion caused by minor head injuries

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Symptoms at one year following concussion from minor head injuries

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Neurobehavioral outcome following minor head injury: a three-center study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Executive functioning, attention and frontal lesions in patients with chronic CHI.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Brain injury, cognitive impairment, and donepezil.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Chronic effects of traumatic brain injury on hippocampal vesicular acetylcholine transporter and M2 muscarinic receptor protein in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Traumatic brain injury reduces hippocampal high-affinity [3H]choline uptake but not extracellular choline levels in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The effect of concussive head injury on central cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Loss of forebrain cholinergic neurons following fluid-percussion injury: implications for cognitive impairment in closed head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Depletion of choline acetyltransferase activity but preservation of M1 and M2 muscarinic receptor binding sites in temporal cortex following head injury: a preliminary human postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Cortical cholinergic dysfunction after human head injury

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Acetylcholine: a neurotransmitter for learning and memory?

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Cognitive evoked potential (P300): a metric for cerebral concussion

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Cognitive models and cholinergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Pharmacology of memory: cholinergic-glutamatergic interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Schizophrenia and nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Impaired auditory gating and P50 nonsuppression following traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Reduced Hippocampal Volume in Association With P50 Nonsuppression Following Traumatic Brain Injury

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Central nervous system bioaminergic responses to mechanical trauma. An experimental study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Catecholamines predict outcome in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The predictive value of catecholamines in assessing outcome in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Fluid percussion injury causes loss of forebrain choline acetyltransferase and nerve growth factor receptor immunoreactive cells in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Effects of scopolamine treatment on long-term behavioral deficits following concussive brain injury to the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The effects of scopolamine and traumatic brain injury on central cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Effect of tetrahydroaminoacridine, a cholinesterase inhibitor, on cognitive performance following experimental brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Cognitive effects of antipsychotic agents in persons with traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Chlorpromazine-induced psychosis after brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The use of cholinesterase in severe head injury

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Protracted post-traumatic confusional state treated with physostigmine

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Selective effects of cholinergic treatment on verbal memory in posttraumatic amnesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Oral physostigmine and impaired memory in adults with brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Open-label study of donepezil in traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Schizophrenia, sensory gating, and nicotinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Neurophysiological assessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Replication and extension of P50 findings in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Evoked potentials in subjects at risk for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The P50 evoked potential component and mismatch detection in normal volunteers: implications for the study of sensory gating

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Elementary phenotypes in the neurobiological and genetic study of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Gating of auditory P50 in schizophrenics: unique effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

No vigilance deficit found in either young schizophrenic or ADHD subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Neuropsychological function in adults with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

From sensation to cognition

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Protracted post-traumatic encephalopathy. Pathology, pathogenesis and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Consciousness and amnesia after penetrating head injury: neurology and anatomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The post-concussional state: neurophysiological aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Effects of traumatic brain injury on the cholinergic system in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The behavioral neurology of cerebral white matter

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Auditory sensory gating in hippocampal neurons: a model system in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Cholinergic gating of response to auditory stimuli in rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Yohimbine impairs P50 auditory sensory gating in normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Intact verbal and nonverbal short‐term memory following damage to the human hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Effects of sound intensity on a midlatency evoked response to repeated auditory stimuli in schizophrenic and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Neuropsychological dysfunction in parents of schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Transient impairment in P50 auditory sensory gating induced by a cold-pressor test.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Replication of a P50 auditory gating deficit in Australian patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Midlatency auditory evoked responses: differential abnormality of P1 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The gamma band response may account for poor P50 suppression in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Poor P50 suppression among schizophrenia patients and their first-degree biological relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Is P50 suppression a measure of sensory gating in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Gating and habituation of the startle reflex in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Source origin of a 50-msec latency auditory evoked field component in young schizophrenic men

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The effects of lesions of superior temporal gyrus and inferior parietal lobe on temporal and vertex components of the human AEP.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Midlatency auditory evoked responses: differential effects of sleep in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Depth evoked potential and single unit correlates of vertex midlatency auditory evoked responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Generators of middle- and long-latency auditory evoked potentials: implications from studies of patients with bitemporal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Habituation of human limbic neuronal response to sensory stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Multiple brain systems generating the rat auditory evoked potential. II. Dissociation of auditory cortex and non-lemniscal generator systems

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Sensory physiology and catecholamines in schizophrenia and mania

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

The P50 auditory event-evoked potential in adult attention-deficit disorder: comparison with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

Muscarinic acetylcholine receptors activate the acetylcholinesterase gene promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900104-9

7 January 2021

10.1016/S1047-9651(03)00104-9

Identifiers

DOI

1 reference

9 August 2017

1 reference